Sökning: onr:"swepub:oai:DiVA.org:uu-351263" > A health economic s...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06909naa a2200733 4500 | |
001 | oai:DiVA.org:uu-351263 | |
003 | SwePub | |
008 | 180611s2018 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:0d1afe71-0222-4dc0-8800-915a51ec83de | |
009 | oai:prod.swepub.kib.ki.se:137801075 | |
009 | oai:DiVA.org:liu-144030 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3512632 URI |
024 | 7 | a https://doi.org/10.1007/s00198-017-4325-42 DOI |
024 | 7 | a https://lup.lub.lu.se/record/0d1afe71-0222-4dc0-8800-915a51ec83de2 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1378010752 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1440302 URI |
040 | a (SwePub)uud (SwePub)lud (SwePub)kid (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Jonsson, E.u Quantify Res, Hantverkargatan 8, SE-11221 Stockholm, Sweden.,Quantify Research AB,Quantify Research, Stockholm, Sweden4 aut |
245 | 1 0 | a A health economic simulation model for the clinical management of osteoporosis |
264 | c 2017-12-01 | |
264 | 1 | b Springer Science and Business Media LLC,c 2018 |
338 | a print2 rdacarrier | |
500 | a Funding agencies: Medtronic | |
520 | a The objective was to estimate the burden of osteoporosis in Sweden based on current clinical practice and the cost-effectiveness of improvements in the management of osteoporosis over the clinical management compared to current clinical practice. Results showed that better compliance to treatment guidelines is associated with better projected outcomes and cost-savings.IntroductionThe purpose of this study is to estimate the burden of osteoporosis in Sweden based on current clinical practice and the cost-effectiveness of improvements in the management of osteoporosis over the clinical management compared to current clinical practice.MethodsThe analysis was carried out using a model that simulates the individual patients considered for pharmacological treatment during 1 year and their projected osteoporosis treatment pathway, quality-adjusted life years (QALYs) and costs over their remaining lifetime. All patients regardless of treatment or no treatment were simulated. Information on current management of osteoporosis in terms of patient characteristics and treatment patterns were derived from a Swedish osteoporosis research database based on national registers and patient records. Current (standard) clinical management was compared with alternative scenarios mirroring Swedish treatment guidelines.ResultsThe national burden in terms of lost QALYs was estimated at 14,993 QALYs and the total economic cost at €776M. Scenario analyses showed that 382–3864 QALYs could be gained at a cost/QALY ranging from cost-saving to €31368, depending on the scenario. The margin of investment, i.e. the maximum amount that could be invested in the healthcare system to achieve these improvements up to the limit of the willingness to pay/QALY, was estimated at €199M on a population level (€3,634/patient).ConclusionsThe analysis showed that better compliance to treatment guidelines is associated with better projected outcomes and cost-savings. From a cost-effectiveness perspective, there is also considerable room for investment to achieve these improvements in the management of osteoporosis. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi0 (SwePub)303012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Health Care Service and Management, Health Policy and Services and Health Economy0 (SwePub)303012 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Ortopedi0 (SwePub)302112 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Orthopaedics0 (SwePub)302112 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
653 | a Cost | |
653 | a Fracture | |
653 | a Osteoporosis | |
653 | a Quality-of-life | |
653 | a Register | |
653 | a Sweden | |
653 | a Cost | |
653 | a Fracture | |
653 | a Osteoporosis | |
653 | a Quality-of-life | |
653 | a Register | |
653 | a Sweden | |
700 | 1 | a Hansson-Hedblom, A.u Quantify Res, Hantverkargatan 8, SE-11221 Stockholm, Sweden.,Quantify Research AB,Quantify Research, Stockholm, Sweden4 aut |
700 | 1 | a Ljunggren, Östenu Uppsala universitet,Endokrinologi och mineralmetabolism,Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden4 aut0 (Swepub:uu)osteljun |
700 | 1 | a Åkesson, K.u Lund University,Lunds universitet,Ortopedi - klinisk och molekylär osteoporosforskning,Forskargrupper vid Lunds universitet,Orthopedics - Clinical and Molecular Osteoporosis Research,Lund University Research Groups,University of Sheffield, Sheffield, UK; Catholic University of Australia, Melbourne, Australia,Australian Catholic University,Department of Clinical Sciences, Clinical and Molecular Osteoporosis Unit, Lund University, Malmö, Sweden4 aut0 (Swepub:lu)orto-kak |
700 | 1 | a Spångeus, Anna,d 1975-u Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Endokrinmedicinska kliniken4 aut0 (Swepub:liu)annsp18 |
700 | 1 | a Kanis, J. A.u Univ Sheffield, Sheffield, S Yorkshire, England.;Catholic Univ Australia, Melbourne, Vic, Australia.4 aut |
700 | 1 | a Borgstrom, F.u Karolinska Institutet,Karolinska Institute,Quantify Research AB,Quantify Research, Stockholm; Karolinska Institutet, Stockholm, Sweden4 aut |
710 | 2 | a Quantify Res, Hantverkargatan 8, SE-11221 Stockholm, Sweden.b Quantify Research AB4 org |
773 | 0 | t Osteoporosis Internationald : Springer Science and Business Media LLCg 29:3, s. 545-555q 29:3<545-555x 0937-941Xx 1433-2965 |
856 | 4 | u http://liu.diva-portal.org/smash/get/diva2:1170625/FULLTEXT01 |
856 | 4 | u http://dx.doi.org/10.1007/s00198-017-4325-4y FULLTEXT |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:1170625/FULLTEXT01.pdfx primaryx Raw objecty fulltext:postprint |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-351263 |
856 | 4 8 | u https://doi.org/10.1007/s00198-017-4325-4 |
856 | 4 8 | u https://lup.lub.lu.se/record/0d1afe71-0222-4dc0-8800-915a51ec83de |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:137801075 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-144030 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy